ACEBROPHYLLINE+MONTELUKAST is a respiratory medication, primarily used to treat and prevent respiratory disorders like asthma attacks, chronic obstructive pulmonary diseases (COPD) and allergic rhinitis (hay fever). Asthma is a breathing problem in which airways narrow, swell and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases that mainly include emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Allergic rhinitis is an inflammation of the nose caused by an allergen, such as pollen, dust, mould, or flakes of skin from certain animals.

ACEBROPHYLLINE+MONTELUKAST is a combination of two medicines: Acebrophylline (bronchodilator) and Montelukast (leukotriene receptor antagonist). Acebrophylline works by relaxing muscles and widening the airways of the lungs. Acebrophylline also has mucoregulating/mucolytic (dissolves thick mucus and helps relieve breathing difficulties) and anti-inflammatory properties. Montelukast blocks the leukotrienes (chemicals released in response when a body comes in contact with an allergen), thereby reducing inflammation and swelling in the nose. It also inhibits bronchoconstriction (narrowing of airways in the lungs that lead to breathing difficulties) and is used in treating asthma and allergic rhinitis.